News & Events

News 2015

  • Cell Therapy Catapult Signs Multiple Collaboration Agreements

    30 March 2015

    30th March 2015 New programmes aim to accelerate regenerative medicine The Cell Therapy Catapult has announced four separate collaborations with multiple-partners to deliver health and wealth to the UK through support from Innovate UK, formerly the Technology Strategy Board. The... read more

  • UCL translational research incubator at Stevenage Bioscience Catalyst

    25 March 2015

    25th March 2015 UCL’s bioscience incubator at the Stevenage Bioscience Catalyst (SBC) has now reached capacity following the migration of two further research projects to the facility from the university’s central London campus. The new research projects have been strategically... read more

  • A tribute to Dr Allan Baxter 1950-2015

    17 February 2015

    Dr Allan Baxter, who died at the end of January, played a major role at Stevenage Bioscience Catalyst right from its inception. With leadership at the Board level as our first Chairman, guidance and participation in our activities, and enthusiasm for our tenants and their work, he brought his... read more

  • NanoScientium delivers business-critical support to VaccineTab

    9 February 2015

    February 2015 NanoScientium announces the completion of a project with VaccineTab, a start-up from Queen’s University Belfast. VaccineTab, led by Dr Vicky Kett, has a proprietary vaccine delivery technology which is thermally stable, therefore reducing the need for cold chain storage and... read more

  • Plasticell wins Innovate UK funding for £1.6million cord blood stem ce

    9 February 2015

    5th February 2015 Innovate UK will provide a grant of approximately £1.3 million to a research consortium led by Plasticell for a project entitled ‘Ex-vivo expansion of cordblood and bone marrow stem cells”. The consortium includes the University of Oxford and the Cell Therapy... read more

  • Six new approaches to fighting neurodegeneration to be funded in SBC's

    24 January 2015

    Six new approaches to fighting neurodegeneration to be funded in SBC's OI challenge Diverse players collaborate on first step in plan to tackle disorder via open innovation Stevenage UK, January 21 2015 – Stevenage Bioscience Catalyst (SBC), the UK’s first open innovation... read more

  • Stevenage Bioscience Catalyst Chair steps down due to illness

    12 January 2015

    Allan Baxter has stepped down as Chair of Stevenage Bioscience Catalyst (SBC) due to an unexpected deterioration in a long-standing health condition. John Cooper, the Wellcome Trust’s nominated Director of SBC has taken over as Interim Chair of the company with immediate effect. Allan had... read more


Funding Partners: